142 related articles for article (PubMed ID: 37814183)
1. Expression of Wnt5a and ROR2, Components of the Noncanonical Wnt-Signaling Pathway, is Associated with Tumor Differentiation in Hepatocellular Carcinoma.
Wakizaka K; Kamiyama T; Kakisaka T; Orimo T; Nagatsu A; Aiyama T; Shichi S; Taketomi A
Ann Surg Oncol; 2024 Jan; 31(1):262-271. PubMed ID: 37814183
[TBL] [Abstract][Full Text] [Related]
2. Loss of Wnt5a and Ror2 protein in hepatocellular carcinoma associated with poor prognosis.
Geng M; Cao YC; Chen YJ; Jiang H; Bi LQ; Liu XH
World J Gastroenterol; 2012 Mar; 18(12):1328-38. PubMed ID: 22493546
[TBL] [Abstract][Full Text] [Related]
3. The Wnt5a/Ror2 noncanonical signaling pathway inhibits canonical Wnt signaling in K562 cells.
Yuan Y; Niu CC; Deng G; Li ZQ; Pan J; Zhao C; Yang ZL; Si WK
Int J Mol Med; 2011 Jan; 27(1):63-9. PubMed ID: 21069266
[TBL] [Abstract][Full Text] [Related]
4. Wnt5a-Ror2 signaling between osteoblast-lineage cells and osteoclast precursors enhances osteoclastogenesis.
Maeda K; Kobayashi Y; Udagawa N; Uehara S; Ishihara A; Mizoguchi T; Kikuchi Y; Takada I; Kato S; Kani S; Nishita M; Marumo K; Martin TJ; Minami Y; Takahashi N
Nat Med; 2012 Feb; 18(3):405-12. PubMed ID: 22344299
[TBL] [Abstract][Full Text] [Related]
5. Wnt5a suppresses osteoblastic differentiation of human periodontal ligament stem cell-like cells via Ror2/JNK signaling.
Hasegawa D; Wada N; Yoshida S; Mitarai H; Arima M; Tomokiyo A; Hamano S; Sugii H; Maeda H
J Cell Physiol; 2018 Feb; 233(2):1752-1762. PubMed ID: 28681925
[TBL] [Abstract][Full Text] [Related]
6. Canonical Wnt signaling is antagonized by noncanonical Wnt5a in hepatocellular carcinoma cells.
Yuzugullu H; Benhaj K; Ozturk N; Senturk S; Celik E; Toylu A; Tasdemir N; Yilmaz M; Erdal E; Akcali KC; Atabey N; Ozturk M
Mol Cancer; 2009 Oct; 8():90. PubMed ID: 19849855
[TBL] [Abstract][Full Text] [Related]
7. Dysregulation of WNT5A/ROR2 Signaling Characterizes the Progression of Barrett-Associated Esophageal Adenocarcinoma.
Lyros O; Nie L; Moore T; Medda R; Otterson M; Behmaram B; Mackinnon A; Gockel I; Shaker R; Rafiee P
Mol Cancer Res; 2016 Jul; 14(7):647-59. PubMed ID: 27084312
[TBL] [Abstract][Full Text] [Related]
8. Comparative study of ROR2 and WNT5a expression in squamous/adenosquamous carcinoma and adenocarcinoma of the gallbladder.
Wu ZC; Xiong L; Wang LX; Miao XY; Liu ZR; Li DQ; Zou Q; Liu KJ; Zhao H; Yang ZL
World J Gastroenterol; 2017 Apr; 23(14):2601-2612. PubMed ID: 28465645
[TBL] [Abstract][Full Text] [Related]
9. Myeloma cells inhibit non-canonical wnt co-receptor ror2 expression in human bone marrow osteoprogenitor cells: effect of wnt5a/ror2 pathway activation on the osteogenic differentiation impairment induced by myeloma cells.
Bolzoni M; Donofrio G; Storti P; Guasco D; Toscani D; Lazzaretti M; Bonomini S; Agnelli L; Capocefalo A; Dalla Palma B; Neri A; Nicolini F; Lisignoli G; Russo F; Colla S; Aversa F; Giuliani N
Leukemia; 2013 Feb; 27(2):451-63. PubMed ID: 22781592
[TBL] [Abstract][Full Text] [Related]
10. The Wnt5a/Ror2 pathway is associated with determination of the differentiation fate of bone marrow mesenchymal stem cells in vascular calcification.
Xin H; Xin F; Zhou S; Guan S
Int J Mol Med; 2013 Mar; 31(3):583-8. PubMed ID: 23337931
[TBL] [Abstract][Full Text] [Related]
11. Over-expression of ROR2 and Wnt5a cooperatively correlates with unfavorable prognosis in patients with non-small cell lung cancer.
Lu C; Wang X; Zhu H; Feng J; Ni S; Huang J
Oncotarget; 2015 Sep; 6(28):24912-21. PubMed ID: 26305508
[TBL] [Abstract][Full Text] [Related]
12. Role of Wnt5a in suppressing invasiveness of hepatocellular carcinoma via epithelial-mesenchymal transition.
Wakizaka K; Kamiyama T; Wakayama K; Orimo T; Shimada S; Nagatsu A; Kamachi H; Yokoo H; Fukai M; Kobayashi N; Mitsuhashi T; Taketomi A
Oncol Lett; 2020 Nov; 20(5):268. PubMed ID: 32989402
[TBL] [Abstract][Full Text] [Related]
13. The WNT5A/ROR2 signaling pathway in pancreatic ductal adenocarcinoma (PDAC).
Remtisch L; Wiltberger G; Schierle K; Yousef M; Thieme R; Jansen Winkeln B; Wittekind C; Gockel I; Lyros O
J BUON; 2021; 26(4):1595-1606. PubMed ID: 34565024
[TBL] [Abstract][Full Text] [Related]
14. CK1ε and p120-catenin control Ror2 function in noncanonical Wnt signaling.
Curto J; Del Valle-Pérez B; Villarroel A; Fuertes G; Vinyoles M; Peña R; García de Herreros A; Duñach M
Mol Oncol; 2018 May; 12(5):611-629. PubMed ID: 29465811
[TBL] [Abstract][Full Text] [Related]
15. Critical roles of Wnt5a-Ror2 signaling in aggressiveness of tongue squamous cell carcinoma and production of matrix metalloproteinase-2 via ΔNp63β-mediated epithelial-mesenchymal transition.
Sakamoto T; Kawano S; Matsubara R; Goto Y; Jinno T; Maruse Y; Kaneko N; Hashiguchi Y; Hattori T; Tanaka S; Kitamura R; Kiyoshima T; Nakamura S
Oral Oncol; 2017 Jun; 69():15-25. PubMed ID: 28559016
[TBL] [Abstract][Full Text] [Related]
16. High expression levels of Wnt5a and Ror2 in laryngeal squamous cell carcinoma are associated with poor prognosis.
Zhang W; Yan Y; Gu M; Wang X; Zhu H; Zhang S; Wang W
Oncol Lett; 2017 Aug; 14(2):2232-2238. PubMed ID: 28781662
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of Ror2 and Wnt5a expression in medulloblastoma.
Lee SE; Lim SD; Kang SY; Suh SB; Suh YL
Brain Pathol; 2013 Jul; 23(4):445-53. PubMed ID: 23278988
[TBL] [Abstract][Full Text] [Related]
18. Stable genetic alterations of β-catenin and ROR2 regulate the Wnt pathway, affect the fate of MSCs.
Cai SX; Liu AR; He HL; Chen QH; Yang Y; Guo FM; Huang YZ; Liu L; Qiu HB
J Cell Physiol; 2014 Jun; 229(6):791-800. PubMed ID: 24590964
[TBL] [Abstract][Full Text] [Related]
19. WNT5a Signaling through ROR2 Activates the Hippo Pathway to Suppress YAP1 Activity and Tumor Growth.
Wang K; Ma F; Arai S; Wang Y; Varkaris A; Poluben L; Voznesensky O; Xie F; Zhang X; Yuan X; Balk SP
Cancer Res; 2023 Apr; 83(7):1016-1030. PubMed ID: 36622276
[TBL] [Abstract][Full Text] [Related]
20. Expression of hepatic Wnt5a and its clinicopathological features in patients with hepatocellular carcinoma.
Wang L; Yao M; Fang M; Zheng WJ; Dong ZZ; Pan LH; Zhang HJ; Yao DF
Hepatobiliary Pancreat Dis Int; 2018 Jun; 17(3):227-232. PubMed ID: 29709351
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
